Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Platelet-rich plasma may help with hair growth and skin quality but more research is needed to confirm its effectiveness.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Micro-needling effectively improves wrinkles, scars, and hair growth, but proper technique and safety are important.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.